These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 4095360)
1. [New method for the determination of estrogen and progesterone receptors in human breast cell lines]. Olea N; Devleeschower N; Leclercq G Rev Esp Fisiol; 1985 Dec; 41(4):373-80. PubMed ID: 4095360 [TBL] [Abstract][Full Text] [Related]
2. Estrone receptor formation during the processing of estradiol-receptor complex in MCF-7 cells. Hansen ER; Brooks SC Cancer Res; 1982 May; 42(5):1967-74. PubMed ID: 7066908 [TBL] [Abstract][Full Text] [Related]
3. Assay for estrogen and progesterone receptors of breast cancer cell lines in monolayer culture. Olea-Serrano N; Devleeschouwer N; Leclercq G; Heuson JC Eur J Cancer Clin Oncol; 1985 Aug; 21(8):965-73. PubMed ID: 4043179 [TBL] [Abstract][Full Text] [Related]
4. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells. Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074 [TBL] [Abstract][Full Text] [Related]
5. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines. Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR Anticancer Res; 1999; 19(1A):269-75. PubMed ID: 10226553 [TBL] [Abstract][Full Text] [Related]
6. Effects of Org OD14 (Livial) and its metabolites on 17 beta-hydroxysteroid dehydrogenase activity in hormone-dependent MCF-7 and T-47D breast cancer cells. Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR Anticancer Res; 1999; 19(1A):261-7. PubMed ID: 10226552 [TBL] [Abstract][Full Text] [Related]
7. Binding characteristics and biological activity of 17 alpha-[125I]iodovinyl-11 beta-methoxyestradiol, an estrogen receptor-binding radiopharmaceutical, in human breast cancer cells (MCF-7). McManaway ME; Jagoda EM; Eckelman WC; Larson SM; Francis BE; Gibson RE; Reba RC; Lippman ME Cancer Res; 1986 May; 46(5):2386-9. PubMed ID: 3697981 [TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of an estrogen-inhibited variant derived from the MCF-7 breast cancer cell line. Bronzert DA; Triche TJ; Gleason P; Lippman ME Cancer Res; 1984 Sep; 44(9):3942-51. PubMed ID: 6744309 [TBL] [Abstract][Full Text] [Related]
9. Characterization and assay of progesterone receptor in human mammary carcinoma. Pichon MF; Milgrom E Cancer Res; 1977 Feb; 37(2):464-71. PubMed ID: 832270 [TBL] [Abstract][Full Text] [Related]
10. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Miller MA; Lippman ME; Katzenellenbogen BS Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162 [TBL] [Abstract][Full Text] [Related]
11. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines. Pihie AH; Stanslas J; Din LB Anticancer Res; 1998; 18(3A):1739-43. PubMed ID: 9673398 [TBL] [Abstract][Full Text] [Related]
12. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors]. Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808 [TBL] [Abstract][Full Text] [Related]
13. Failure of estradiol immunofluorescence in MCF-7 breast cancer cells to detect estrogen receptors. Mercer WD; Edwards DP; Chamness GC; McGuire WL Cancer Res; 1981 Nov; 41(11 Pt 1):4644-52. PubMed ID: 7030480 [TBL] [Abstract][Full Text] [Related]
14. The anti-aromatase effect of progesterone and of its natural metabolites 20alpha- and 5alpha-dihydroprogesterone in the MCF-7aro breast cancer cell line. Pasqualini JR; Chetrite G Anticancer Res; 2008; 28(4B):2129-33. PubMed ID: 18751385 [TBL] [Abstract][Full Text] [Related]
15. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. Murphy LJ; Murphy LC; Vrhovsek E; Sutherland RL; Lazarus L Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992 [TBL] [Abstract][Full Text] [Related]
16. Reduction of estrogen receptor concentration in MCF-7 human breast carcinoma cells following exposure to chemotherapeutic drugs. Yang KP; Samaan NA Cancer Res; 1983 Aug; 43(8):3534-8. PubMed ID: 6861126 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648 [TBL] [Abstract][Full Text] [Related]
18. Growth inhibition by progestins in a human endometrial cancer cell line with estrogen-independent progesterone receptors. Terakawa N; Hayashida M; Shimizu I; Ikegami H; Wakimoto H; Aono T; Tanizawa O; Matsumoto K; Nishida M Cancer Res; 1987 Apr; 47(7):1918-23. PubMed ID: 3815380 [TBL] [Abstract][Full Text] [Related]